Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$94.9K Buy
1,020
+4
+0.4% +$354 ﹤0.01% 1379
2025
Q4
$81.6K Sell
1,016
-14
-1% -$1.17K ﹤0.01% 1405
2025
Q3
$101K Buy
1,030
+15
+1% +$1.21K ﹤0.01% 1302
2025
Q2
$70.7K Sell
1,015
-279
-22% -$15.9K ﹤0.01% 1405
2025
Q1
$64.3K Buy
1,294
+930
+255% +$58.8K ﹤0.01% 1432
2024
Q4
$25.4K Buy
364
+173
+91% +$14.4K ﹤0.01% 1938
2024
Q3
$20K Sell
191
-20
-9% -$2.34K ﹤0.01% 2041
2024
Q2
$30K Buy
211
+164
+349% +$18.9K ﹤0.01% 1767
2024
Q1
$5.24K Sell
47
-9
-16% -$1.07K ﹤0.01% 2517
2023
Q4
$7.26K Sell
56
-62
-53% -$8.54K ﹤0.01% 2389
2023
Q3
$19.2K Buy
118
+55
+87% +$9.67K ﹤0.01% 1872
2023
Q2
$11.6K Buy
63
+7
+13% +$1.01K ﹤0.01% 2175
2023
Q1
$7.46K Buy
56
+13
+30% +$1.53K ﹤0.01% 2342
2022
Q4
$3.41K Sell
43
-2
-4% -$141 ﹤0.01% 2621
2022
Q3
$3K Buy
45
+18
+67% +$1.16K ﹤0.01% 2595
2022
Q2
$1K Sell
27
-23
-46% -$1.33K ﹤0.01% 2862
2022
Q1
$4K Buy
50
+27
+117% +$1.84K ﹤0.01% 2546
2021
Q4
$2K Hold
23
﹤0.01% 2660
2021
Q3
$1K Buy
+23
New +$1K ﹤0.01% 2758

Other funds holding ACLS

SignatureFD's ACLS Position: Q1 2026 in Review

SignatureFD increased its Axcelis (ACLS) stake by 0.39% in Q1 2026, buying an estimated $354 and bringing the position to 1,020 shares worth $94.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1379.

SignatureFD first reported a position in ACLS in Q3 2021 and has held it in 19 quarters since. The position peaked at $101K in Q3 2025. 377 funds tracked by Wall St. Rank hold ACLS as of Q1 2026.

  • SignatureFD held 1,020 shares of Axcelis worth $94.9K as of Q1 2026.
  • SignatureFD bought 4 Axcelis shares in Q1 2026, an estimated $354.
  • Axcelis made up ﹤0.01% of SignatureFD's portfolio in Q1 2026, its #1379 holding.
  • SignatureFD first reported a position in Axcelis in Q3 2021 and has held it in 19 quarters since.
  • SignatureFD's Axcelis position peaked at $101K in Q3 2025.
  • 377 funds tracked by Wall St. Rank held Axcelis as of Q1 2026.

Based on SignatureFD's 13F filing for Q1 2026, filed 7 Apr 2026.